Entering text into the input field will update the search result below

Myriad Genetics to acquire Counsyl for $375M in cash and stock

May 29, 2018 6:46 AM ETMyriad Genetics, Inc. (MYGN) StockBy: Douglas W. House, SA News Editor
  • Myriad Genetics (NASDAQ:MYGN) has agreed to acquire genetic testing provider Counsyl for $375M, of which up to 25% can be MYGN stock. The transaction should close in calendar Q3.
  • South San Francisco, CA-based Counsyl, founded in 2007, provides reproductive and cancer testing services.
  • MYGN will host a conference call this morning at 7:30 am to discuss the deal.

Recommended For You

More Trending News

About MYGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MYGN--
Myriad Genetics, Inc.